Dec 6 (Reuters) - Suda Pharmaceuticals Ltd (SUD) :
- SUDA PHARMACEUTICALS LTD - ENTERS INTO A FULLY FUNDED FEASIBILITY & OPTION AGREEMENT WITH ZELDA THERAPEUTICS
- SUDA PHARMACEUTICALS LTD - CO TO APPLY PROPRIETARY OROMIST ORO-MUCOSAL SPRAY TECHNOLOGY TO ZELDA'S PHARMACEUTICAL-GRADE CANNABINOID DERIVATIVES
Source text: (http//bit.ly/2G3bbpY)
(([email protected];))